{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:55:48Z","timestamp":1790420148642,"version":"4.1.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2023,9,1]]},"abstract":"<jats:sec id=\"ab-soi230032-4\"><jats:title>Importance<\/jats:title><jats:p>Lymphedema is a debilitating condition that affects approximately 1 in 1000 individuals in the United States. Complete decongestive therapy is currently the standard of care, and innovative surgical techniques have demonstrated potential to further improve outcomes. Despite the growing armamentarium of treatment options, a large proportion of patients with lymphedema continue to struggle because of limited access to care.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230032-5\"><jats:title>Objective<\/jats:title><jats:p>To define the current state of insurance coverage for lymphedema treatments in the United States.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230032-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>A cross-sectional analysis of insurance reimbursement for lymphedema treatments in 2022 was designed. The top 3 insurance companies per state based on market share and enrollment data maintained by the Kaiser Family Foundation were included. Established medical policies were gathered from insurance company websites and phone interviews, and descriptive statistics were performed.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230032-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Treatments of interest included nonprogrammable pneumatic compression, programmable pneumatic compression, surgical debulking, and physiologic procedures. Primary outcomes included level of coverage and criteria for coverage.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230032-8\"><jats:title>Results<\/jats:title><jats:p>This study included 67 health insurance companies representing 88.7% of the US market share. Most insurance companies offered coverage for nonprogrammable (n\u2009=\u200955, 82.1%) and programmable (n\u2009=\u200953, 79.1%) pneumatic compression. However, few insurance companies offered coverage for debulking (n\u2009=\u200913, 19.4%) or physiologic (n\u2009=\u20095, 7.5%) procedures. Geographically, the lowest rates of coverage were seen in the West, Southwest, and Southeast.<\/jats:p><\/jats:sec><jats:sec id=\"ab-soi230032-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study suggests that in the United States, less than 12% of individuals with health insurance, and even fewer patients without health insurance, have access to pneumatic compression and surgical treatments for lymphedema. The stark inadequacy of insurance coverage must be addressed through research and lobbying efforts to mitigate health disparities and promote health equity among patients with lymphedema.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamasurg.2023.2017","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T15:03:50Z","timestamp":1686150230000},"page":"920","source":"Crossref","is-referenced-by-count":17,"title":["Cross-Sectional Analysis of Insurance Coverage for Lymphedema Treatments in the United States"],"prefix":"10.1001","volume":"158","author":[{"given":"Jeremy V.","family":"Lynn","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey E.","family":"Hespe","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen F.","family":"Akhter","sequence":"additional","affiliation":[{"name":"Central Michigan University College of Medicine, Saginaw"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle M.","family":"David","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore A.","family":"Kung","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Myers","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"soi230032r1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1196\/nyas.2008.1131.issue-1","article-title":"Estimating the population burden of lymphedema.","volume":"1131","author":"Rockson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"soi230032r2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.suronc.2020.09.005","article-title":"Epidemiology of lymphedema-related admissions in the United States: 2012-2017.","volume":"35","author":"Lopez","year":"2020","journal-title":"Surg Oncol"},{"issue":"20","key":"soi230032r3","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","article-title":"Lymphedema after breast cancer treatment.","volume":"379","author":"Rockson","year":"2018","journal-title":"N Engl J Med"},{"issue":"4S","key":"soi230032r4","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1097\/SAP.0000000000001864","article-title":"Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach.","volume":"82","author":"Johnson","year":"2019","journal-title":"Ann Plast Surg"},{"issue":"6","key":"soi230032r5","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.21037\/tcr","article-title":"Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis.","volume":"11","author":"Hu","year":"2022","journal-title":"Transl Cancer Res"},{"issue":"2","key":"soi230032r6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpainsymman.2011.03.019","article-title":"Prevalence of secondary lymphedema in patients with head and neck cancer.","volume":"43","author":"Deng","year":"2012","journal-title":"J Pain Symptom Manage"},{"issue":"22","key":"soi230032r7","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1002\/cncr.25458","article-title":"Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema.","volume":"116","author":"Cormier","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"soi230032r8","first-page":"170","article-title":"The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology.","volume":"49","author":"Executive Committee of the International Society of Lymphology","year":"2016","journal-title":"Lymphology"},{"issue":"1","key":"soi230032r9","first-page":"3","article-title":"The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology.","volume":"53","author":"Executive Committee of the International Society of Lymphology","year":"2020","journal-title":"Lymphology"},{"issue":"6","key":"soi230032r10","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/bjd.15699","article-title":"A comparison of programmable and nonprogrammable compression devices for treatment of lymphoedema using an administrative health outcomes dataset.","volume":"177","author":"Karaca-Mandic","year":"2017","journal-title":"Br J Dermatol"},{"issue":"3","key":"soi230032r11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/PRS.0000000000005993","article-title":"Surgical treatment of lymphedema.","volume":"144","author":"Schaverien","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"soi230032r12","first-page":"56","article-title":"Liposuction in lymphedema treatment.","volume":"32","author":"Brorson","year":"2016","journal-title":"J Reconstr Microsurg"},{"issue":"8","key":"soi230032r13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1089\/wound.2021.0005","article-title":"Updates on excisional procedures for lymphedema.","volume":"11","author":"Viviano","year":"2022","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"3","key":"soi230032r14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.sla.0000201258.10304.16","article-title":"Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation.","volume":"243","author":"Becker","year":"2006","journal-title":"Ann Surg"},{"issue":"5","key":"soi230032r15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jso.v118.5","article-title":"Lymphovenous bypass for the treatment of lymphedema.","volume":"118","author":"Garza","year":"2018","journal-title":"J Surg Oncol"},{"issue":"1","key":"soi230032r16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0038-1632401","article-title":"Vascularized lymph node transfer for lymphedema.","volume":"32","author":"Schaverien","year":"2018","journal-title":"Semin Plast Surg"},{"key":"soi230032r17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.avsg.2019.08.091","article-title":"Superior clinical, quality of life, functional, and health economic outcomes with pneumatic compression therapy for lymphedema.","volume":"63","author":"Desai","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"1","key":"soi230032r18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13561-022-00388-6","article-title":"Cost of a lymphedema treatment mandate: 16?years of experience in the Commonwealth of Virginia.","volume":"12","author":"Weiss","year":"2022","journal-title":"Health Econ Rev"},{"issue":"7","key":"soi230032r19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJMoa1917197","article-title":"Compression therapy to prevent recurrent cellulitis of the leg.","volume":"383","author":"Webb","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"soi230032r20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-00000029","article-title":"Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery.","volume":"32","author":"Penha","year":"2016","journal-title":"J Reconstr Microsurg"},{"issue":"3","key":"soi230032r21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1742395319872796","article-title":"Breast cancer-related lymphedema and quality of life: a qualitative analysis over years of survivorship.","volume":"17","author":"Anbari","year":"2021","journal-title":"Chronic Illn"},{"issue":"10","key":"soi230032r22","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3390\/jcm9103200","article-title":"The quality of life and psychosocial implications of cancer-related lower-extremity lymphedema: a systematic review of the literature.","volume":"9","author":"Bowman","year":"2020","journal-title":"J Clin Med"},{"issue":"5","key":"soi230032r23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00520-018-4418-4","article-title":"\u201cIt still affects our economic situation\u201d: long-term economic burden of breast cancer and lymphedema.","volume":"27","author":"Dean","year":"2019","journal-title":"Support Care Cancer"},{"issue":"4","key":"soi230032r24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jvsv.2022.03.008","article-title":"A review of American insurance coverage and criteria for conservative management of lymphedema.","volume":"10","author":"Finkelstein","year":"2022","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"3","key":"soi230032r25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.2008.17.9291","article-title":"Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.","volume":"27","author":"Norman","year":"2009","journal-title":"J Clin Oncol"},{"issue":"5","key":"soi230032r26","doi-asserted-by":"publisher","first-page":"539e","DOI":"10.1097\/PRS.0000000000007241","article-title":"Navigating the insurance landscape for coverage of reduction mammaplasty.","volume":"146","author":"Rawes","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"soi230032r28","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/SAP.0000000000002263","article-title":"The Charles procedure as part of the modern armamentarium against lymphedema.","volume":"85","author":"Hassan","year":"2020","journal-title":"Ann Plast Surg"},{"issue":"6","key":"soi230032r29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/micr.v34.6","article-title":"Modified Charles procedure and lymph node flap transfer for advanced lower extremity lymphedema.","volume":"34","author":"Sapountzis","year":"2014","journal-title":"Microsurgery"},{"issue":"6","key":"soi230032r30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/SAP.0b013e318180cd24","article-title":"Modified Charles procedure using negative pressure dressings for primary lymphedema: a functional assessment.","volume":"62","author":"van der Walt","year":"2009","journal-title":"Ann Plast Surg"},{"key":"soi230032r31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/med.2018.69.issue-1","article-title":"Lymphedema: pathogenesis and novel therapies.","volume":"69","author":"Dayan","year":"2018","journal-title":"Annu Rev Med"},{"issue":"1","key":"soi230032r32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0038-1635116","article-title":"Liposuction treatment of lymphedema.","volume":"32","author":"Schaverien","year":"2018","journal-title":"Semin Plast Surg"},{"issue":"1","key":"soi230032r33","first-page":"27","article-title":"A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011).","volume":"46","author":"Stout","year":"2013","journal-title":"Lymphology"},{"issue":"1","key":"soi230032r34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3322\/caac.21253","article-title":"Recent progress in the treatment and prevention of cancer-related lymphedema.","volume":"65","author":"Shaitelman","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"soi230032r35","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.pmrj.2012.05.003","article-title":"A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011.","volume":"4","author":"Lasinski","year":"2012","journal-title":"PM R"},{"issue":"5","key":"soi230032r36","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1097\/PRS.0b013e3182a4d626","article-title":"A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.","volume":"132","author":"Chang","year":"2013","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"soi230032r37","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/0007-1226(90)90123-H","article-title":"Lymph node transfer for the treatment of obstructive lymphoedema in the canine model.","volume":"43","author":"Chen","year":"1990","journal-title":"Br J Plast Surg"},{"issue":"4","key":"soi230032r38","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/PRS.0b013e31819e6529","article-title":"Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema.","volume":"123","author":"Lin","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"soi230032r39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/PRS.0000000000000010","article-title":"Operative treatment of peripheral lymphedema: a systematic meta-analysis of the efficacy and safety of lymphovenous microsurgery and tissue transplantation.","volume":"133","author":"Basta","year":"2014","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"soi230032r40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/SAP.0000000000000513","article-title":"Comparison of vascularized supraclavicular lymph node transfer and lymphaticovenular anastomosis for advanced stage lower extremity lymphedema.","volume":"74","author":"Akita","year":"2015","journal-title":"Ann Plast Surg"},{"issue":"1","key":"soi230032r41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jso.25607","article-title":"Vascularized gastroepiploic lymph node transfer significantly improves breast cancer-related lymphedema.","volume":"121","author":"Mousavi","year":"2020","journal-title":"J Surg Oncol"},{"issue":"5","key":"soi230032r42","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1097\/SLA.0000000000000763","article-title":"Vascularized lymph node transfer for treatment of lymphedema: a comprehensive literature review.","volume":"261","author":"Raju","year":"2015","journal-title":"Ann Surg"},{"key":"soi230032r27","unstructured":"Kaiser Family Foundation. Market share and enrolment of largest three insurers: individual market. Accessed March 25, 2022. https:\/\/www.kff.org\/private-insurance\/state-indicator\/market-share-and-enrollment-of-largest-three-insurers-individual-market"},{"key":"soi230032r43","unstructured":"Lymphatic Education and Research Network. Centers of Excellence. Accessed November 26, 2022. https:\/\/lymphaticnetwork.org\/centers-of-excellence"},{"key":"soi230032r44","unstructured":"Library of Congress. S.1315 \u2013 Lymphedema Treatment Act. Accessed November 26, 2022. https:\/\/www.congress.gov\/bill\/117th-congress\/senate-bill\/1315\/all-info"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2805950\/jamasurgery_lynn_2023_oi_230032_1694030442.79258.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:09:46Z","timestamp":1694617786000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2805950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2023.2017","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}